Histogenics (HSGX) Says FDA Indicated Additional Trial Needed to Com...

12/21/18

Histogenics (HSGX) Says FDA Indicated Additional Trial Needed to Complete Submission of BLA for NeoCart  StreetInsider.com

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

[more]